Guidelines
American Society of Hematology Guidelines
Epoetin and Darbepoetin
"American
Society of Hematology/American Society of Clinical Oncology 2010
clinical practice guideline update on the use of epoetin and
darbepoetin"The latest research and evidence-based clinical guidelines about the use of epoetin for the treatment of cancer-related anemia.
-
Data Supplement
"Future directionsThere is clear evidence regarding the ability of ESAs to increase
Hb and avoid transfusions. There is also evidence of harm
associated with their use. Perhaps the most pressing need for
additional research is studies that further clarify the mechanisms of
harm and, particularly, the groups of patients or circumstances of
clinical use that are least associated with these risks. This understanding
is paramount to the ability of clinicians to extend the
benefit of these drugs while reducing the risks."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.